2-years outcomes of the treat-to-target strategy in early psoriatic arthritis

The 2015 guidelines for the laboratory diagnosis of rheumatic diseases by the All-Russian Public Organization «Association of Rheumatology of Russia»

THE 2016 EULAR GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF EARLY ARTHRITIS

The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part I

The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II

4-WEEK OPEN-LABEL CONTROLLED RANDOMIZED COMPARATIVE STUDY OF THE INJECTABLE AND TABLETTED FORMULATIONS OF METHOTREXATE IN RHEUMATOID ARTHRITIS

ABATACEPT FOR RHEUMATOID ARTHRITIS: A NOVEL FORMULATION, NEW MECHANISMS, NEW POSSIBILITIES

ACHIEVEMENT OF MINIMAL DISEASE ACTIVITY AND PROGRESSION OF RADIOGRAPHIC CHANGES IN EARLY PSORIATIC ARTHRITIS ONE YEAR AFTER INITIATION OF TREATMENT IN «TREAT TO TARGET» STRATEGY (PRELIMINARY RESULTS OF THE REMARKA STUDY)

ACHIEVEMENTS IN RHEUMATOLOGY IN THE XXI CENTURY

Achievements in Russian Pediatric Rheumatology: Meeting of the Internal Medicine Sciences’ Council of the Department of Medical Sciences of the Russian Academy of Sciences

Administration of chondroprotector piascledine in the treatment of secondary osteoarthritis in patients with gout

Adult Still's disease: New horizons

Advances in rheumatology at the beginning of the 21st century

ANALYSIS OF THE RESULTS OF TOFACITINIB THERAPY IN REAL CLINICAL PRACTICE ACCORDING TO THE ALL-RUSSIAN ARTHRITIS REGISTRY (OREL)

Anti-carbamylated protein antibodies in ACCP-negative and ACCP-positive patients with rheumatoid arthritis

Anti-inflammatory effects of low- and high-dose atorvastatin therapy in patients with coronary heart disease and rheumatoid arthritis

ANTI-INFLAMMATORY THERAPY FOR ATHEROSCLEROSIS: CONTRIBUTION TO AND LESSONS OF RHEUMATOLOGY

Anti-topoisomerase 1 antibody level changes after B сell depletion therapy in systemic sclerosis

Antibodies to annexin-5 in pregnant women with systemic lupus erythematosus

Antibodies to domain I β2 -glycoprotein 1 in patients with antiphospholipid syndrome and systemic lupus erythematosus